an imperfect compromiseBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7409.286 (Published 31 July 2003) Cite this as: BMJ 2003;327:286
- Martin Dennis, professor of stroke medicine (email@example.com)1
- 1Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU
Boter and colleagues have proposed a compromise to obtaining fully informed consent before enrolment for randomised trials that have primary outcomes based on a subjective measure, which makes blinding impossible and bias likely. This compromise aims to involve the patient and show them as much respect as possible. As with all compromises it is imperfect. From the trialists' point of view it still has several drawbacks compared with obtaining consent only for follow up.
Telling patients that there is a secret additional research question is likely to reduce the proportion of patients who agree to participate …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial